Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Gestational epigenetic age and ADHD symptoms in childhood: a prospective, multi-cohort study

Abstract

Epigenetic age acceleration (EAA), defined as the difference between chronological age and epigenetically predicted age, was calculated from multiple gestational epigenetic clocks (Bohlin, EPIC overlap, and Knight) using DNA methylation levels from cord blood in three large population-based birth cohorts: the Generation R Study (The Netherlands), the Avon Longitudinal Study of Parents and Children (United Kingdom), and the Norwegian Mother, Father and Child Cohort Study (Norway). We hypothesized that a lower EAA associates prospectively with increased ADHD symptoms. We tested our hypotheses in these three cohorts and meta-analyzed the results (n = 3383). We replicated previous research on the association between gestational age (GA) and ADHD. Both clinically measured gestational age as well as epigenetic age measures at birth were negatively associated with ADHD symptoms at ages 5–7 years (clinical GA: β = −0.04, p < 0.001, Bohlin: β = −0.05, p = 0.01; EPIC overlap: β = −0.05, p = 0.01; Knight: β = −0.01, p = 0.26). Raw EAA (difference between clinical and epigenetically estimated gestational age) was positively associated with ADHD in our main model, whereas residual EAA (raw EAA corrected for clinical gestational age) was not associated with ADHD symptoms across cohorts. Overall, findings support a link between lower gestational age (either measured clinically or using epigenetic-derived estimates) and ADHD symptoms. Epigenetic age acceleration does not, however, add unique information about ADHD risk independent of clinically estimated gestational age at birth.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Forest plots of pooled analysis using the Bohlin clock.

References

  1. Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. ADHD prevalence estimates across three decades: An updated systematic review and meta-regression analysis. Int J Epidemiol. 2014;43:434–42.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Das D, Cherbuin N, Butterworth P, Anstey KJ, Easteal S. A population-based study of attention deficit/hyperactivity disorder symptoms and associated impairment in middle-aged adults. PLoS One. 2012;7:e31500.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Vörös Z, Lukovszki L. The effects of subclinical ADHD symptomatology on the subjective financial, physical, and mental well-being of entrepreneurs and employees. J Bus Venturing Insights. 2021;15:e00240.

    Article  Google Scholar 

  4. Wootton RE, Riglin L, Blakey R, Agnew-Blais J, Caye A, Cadman T, et al. Decline in attention-deficit hyperactivity disorder traits over the life course in the general population: Trajectories across five population birth cohorts spanning ages 3 to 45 years. Int J Epidemiol. 2022;51:919–30.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Demontis D, Walters RK, Martin J, Mattheisen M, Als TD, Agerbo E, et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet. 2019;51:63–75.

    Article  CAS  PubMed  Google Scholar 

  6. Kim JH, Kim JY, Lee J, Jeong GH, Lee E, Lee S, et al. Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review. Lancet Psychiatry. 2020;7:955–70.

    Article  PubMed  Google Scholar 

  7. Heinonen K, Räikkönen K, Pesonen AK, Andersson S, Kajantie E, Eriksson JG, et al. Behavioural symptoms of attention deficit/hyperactivity disorder in preterm and term children born small and appropriate for gestational age: A longitudinal study. BMC Pediatr. 2010;10:91.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Cecil CAM, Nigg JT. Epigenetics and ADHD: Reflections on Current Knowledge, Research Priorities and Translational Potential. Mol Diagn Ther. 2022;26:581–606.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Cecil CAM, Neumann A, Walton E. Epigenetics applied to child and adolescent mental health: Progress, challenges and opportunities. JCPP Adv. 2023;3:e12133.

  10. Neumann A, Walton E, Alemany S, Cecil C, González JR, Jima DD, et al. Association between DNA methylation and ADHD symptoms from birth to school age: a prospective meta-analysis. Transl Psychiatry. 2020;10:398.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Walton E, Pingault JB, Cecil CAM, Gaunt TR, Relton CL, Mill J, et al. Epigenetic profiling of ADHD symptoms trajectories: A prospective, methylome-wide study. Mol Psychiatry. 2017;22:250–6.

    Article  CAS  PubMed  Google Scholar 

  12. Oblak L, van der Zaag J, Higgins-Chen AT, Levine ME, Boks MP. A systematic review of biological, social and environmental factors associated with epigenetic clock acceleration. Ageing Res Rev. 2021;69:101348.

    Article  CAS  PubMed  Google Scholar 

  13. McGill MG, Pokhvisneva I, Clappison AS, McEwen LM, Beijers R, Tollenaar MS, et al. Maternal Prenatal Anxiety and the Fetal Origins of Epigenetic Aging. Biol Psychiatry. 2022;91:303–12.

    Article  CAS  PubMed  Google Scholar 

  14. Suarez A, Lahti J, Czamara D, Lahti-Pulkkinen M, Knight AK, Girchenko P, et al. The Epigenetic Clock at Birth: Associations With Maternal Antenatal Depression and Child Psychiatric Problems. J Am Acad Child Adolesc Psychiatry. 2018;57:321–8.e2.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Simpkin AJ, Howe LD, Tilling K, Gaunt TR, Lyttleton O, McArdle WL, et al. The epigenetic clock and physical development during childhood and adolescence: Longitudinal analysis from a UK birth cohort. Int J Epidemiol. 2017;46:549–58.

  16. Bright HD, Howe LD, Khouja JN, Simpkin AJ, Suderman M, O’Keeffe LM. Epigenetic gestational age and trajectories of weight and height during childhood: A prospective cohort study. Clin Epigenetics. 2019;11:194.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bell CG, Lowe R, Adams PD, Baccarelli AA, Beck S, Bell JT, et al. DNA methylation aging clocks: Challenges and recommendations. Genome Biol. 2019;20:249.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Mooney MA, Ryabinin P, Wilmot B, Bhatt P, Mill J, Nigg JT. Large epigenome-wide association study of childhood ADHD identifies peripheral DNA methylation associated with disease and polygenic risk burden. Transl Psychiatry. 2020;10:8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Arpawong TE, Klopack ET, Kim JK, Crimmins EM. ADHD genetic burden associates with older epigenetic age: mediating roles of education, behavioral and sociodemographic factors among older adults. Clin Epigenetics. 2023;15:67.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Monasso GS, Küpers LK, Jaddoe VWV, Heil SG, Felix JF. Associations of circulating folate, vitamin B12 and homocysteine concentrations in early pregnancy and cord blood with epigenetic gestational age: the Generation R Study. Clin Epigenetics. 2021;13:95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Bohlin J, Håberg SE, Magnus P, Reese SE, Gjessing HK, Magnus MC, et al. Prediction of gestational age based on genome-wide differentially methylated regions. Genome Biol. 2016;17:207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Haftorn KL, Lee Y, Denault WRP, Page CM, Nustad HE, Lyle R, et al. An EPIC predictor of gestational age and its application to newborns conceived by assisted reproductive technologies. Clin Epigenetics. 2021;13:82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Knight AK, Craig JM, Theda C, Bækvad-Hansen M, Bybjerg-Grauholm J, Hansen CS, et al. An epigenetic clock for gestational age at birth based on blood methylation data. Genome Biol. 2016;17:206.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kooijman MN, Kruithof CJ, van Duijn CM, Duijts L, Franco OH, van IJzendoorn MH, et al. The Generation R Study: design and cohort update 2017. Eur J Epidemiol. 2016;31:1243–64.

    Article  PubMed  Google Scholar 

  25. Schreuder P, Alsaker E. The Norwegian mother and child cohort study (MoBa) – MoBa recruitment and logistics. Norsk Epidemiol. 2014;24:23–7.

  26. Magnus P, Irgens LM, Haug K, Nystad W, Skjærven R, Stoltenberg C, et al. Cohort profile: The Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol. 2006;35:1146–50.

    Article  PubMed  Google Scholar 

  27. Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, Henderson J, et al. Cohort profile: The ’Children of the 90s’-The index offspring of the avon longitudinal study of parents and children. Int J Epidemiol. 2013;42:111–27.

    Article  PubMed  Google Scholar 

  28. Fraser A, Macdonald-wallis C, Tilling K, Boyd A, Golding J, Davey smith G, et al. Cohort profile: The avon longitudinal study of parents and children: ALSPAC mothers cohort. Int J Epidemiol. 2013;42:97–110.

    Article  PubMed  Google Scholar 

  29. Joubert BR, den Dekker HT, Felix JF, Bohlin J, Ligthart S, Beckett E, et al. Maternal plasma folate impacts differential DNA methylation in an epigenome-wide meta-analysis of newborns. Nat Commun. 2016;7:10577.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Joubert BR, Felix JF, Yousefi P, Bakulski KM, Just AC, Breton C, et al. DNA Methylation in Newborns and Maternal Smoking in Pregnancy: Genome-wide Consortium Meta-analysis. Am J Hum Genet. 2016;98:680–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Mulder RH, Neumann A, Cecil CAM, Walton E, Houtepen LC, Simpkin AJ, et al. Epigenome-wide change and variation in DNA methylation in childhood: Trajectories from birth to late adolescence. Hum Mol Genet. 2021;30:119–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Håberg SE, Page CM, Lee Y, Nustad HE, Magnus MC, Haftorn KL, et al. DNA methylation in newborns conceived by assisted reproductive technology. Nat Commun. 2022;13:1896.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Lehne B, Drong AW, Loh M, Zhang W, Scott WR, Tan ST, et al. Erratum to A coherent approach for analysis of the Illumina HumanMethylation450 BeadChip improves data quality and performance in epigenome-wide association studies [Genome Biol. (2015);16:37], Genome Biol. 2015;17:73.

  34. Min JL, Hemani G, Davey Smith G, Relton C, Suderman M. Meffil: Efficient normalization and analysis of very large DNA methylation datasets. Bioinformatics. 2018;34:3983–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Paltiel L, Anita, H, Skjerden T, Harbak K, Bækken S, Nina Kristin, S, et al. The biobank of the Norwegian mother and child cohort study – Present status. Norsk Epidemiol. 2014;24:29–35.

  36. Pidsley R, Y Wong CC, Volta M, Lunnon K, Mill J, Schalkwyk LC. A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics. 2013;14:293.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Girchenko P, Lahti J, Czamara D, Knight AK, Jones MJ, Suarez A, et al. Associations between maternal risk factors of adverse pregnancy and birth outcomes and the offspring epigenetic clock of gestational age at birth. Clin Epigenetics. 2017;9:49.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Gervin K, Salas LA, Bakulski KM, Van Zelm MC, Koestler DC, Wiencke JK, et al. Systematic evaluation and validation of reference and library selection methods for deconvolution of cord blood DNA methylation data. Clin Epigenetics. 2019;11:125.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Achenbach TM, Ruffle TM. The child behavior checklist and related forms for assessing behavioral/emotional problems and competencies. Pediatr Rev. 2000;21:265–71.

    Article  CAS  PubMed  Google Scholar 

  40. Goodman R. The Strengths and Difficulties Questionnaire_ A Research Note - Goodman − 1997 - Journal of Child Psychology and Psychiatry - Wiley Online Library. J Child Psychol Psychiat. 1997;38:581–6.

    Article  CAS  PubMed  Google Scholar 

  41. Nøvik TS. Validity of the child behaviour checklist in a Norwegian sample. Eur Child Adolesc Psychiatry. 1999;8:247–54.

    Article  PubMed  Google Scholar 

  42. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry. 2000;39:28–38.

    Article  CAS  PubMed  Google Scholar 

  43. Van Mil NH, Steegers-Theunissen RPM, Bouwland-Both MI, Verbiest MMPJ, Rijlaarsdam J, Hofman A, et al. DNA methylation profiles at birth and child ADHD symptoms. J Psychiatr Res. 2014;49:51–9.

    Article  PubMed  Google Scholar 

  44. Goodman R, Scott S. Comparing the Strengths and Difficulties Questionnaire and the child behavior checklist: Is small beautiful? J Abnorm Child Psychol. 1999;27:17–24.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The Generation R Study is conducted by Erasmus MC, University Medical Center Rotterdam in close collaboration with the School of Law and Faculty of Social Sciences of the Erasmus University Rotterdam, the Municipal Health Service Rotterdam area, Rotterdam, the Rotterdam Homecare Foundation, Rotterdam and the Stichting Trombosedienst & Artsenlaboratorium Rijnmond (STAR-MDC), Rotterdam. We gratefully acknowledge the contribution of children and parents, general practitioners, hospitals, midwives and pharmacies in Rotterdam. The generation and management of the Illumina 450 K methylation array data (EWAS data) for the Generation R Study was executed by the Human Genotyping Facility of the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC, and the Netherlands. We thank Mr. Michael Verbiest, Ms. Mila Jhamai, Ms. Sarah Higgins, Mr. Marijn Verkerk and Dr. Lisette Stolk for their help in creating the EWAS database. We thank Dr. Alexander Teumer for his work on the quality control and normalization scripts. We are extremely grateful to all the families who took part in the ALSPAC study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and KS will serve as guarantors for the contents of this paper. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. We are grateful to all the participating families in Norway who take part in this on-going cohort study. The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health, and the Norwegian Research Council/FUGE (grant no. 151918/S10). This work was partly supported by the Research Council of Norway through its Centers of Excellence funding scheme, project number 262700 and Grant Number 288083, 301004. The general design of the Generation R Study is made possible by financial support from the Erasmus MC, Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development and the Ministry of Health, Welfare and Sport. The EWAS data were funded by a grant from the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) Netherlands Consortium for Healthy Aging (NCHA; project nr. 050-060-810), by funds from the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC, and by a grant from the National Institute of Child and Human Development (R01HD068437). This project received funding from the European Union’s Horizon 2020 research and innovation programme (874739, LongITools; 824989, EUCAN-Connect) and from the European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL, NutriPROGRAM project, ZonMw the Netherlands no.529051022). CAMC and EW are supported by the European Union’s Horizon 2020 Research and Innovation Programme (EarlyCause, grant agreement No 848158); CAMC is also supported by the European Union’s HorizonEurope Research and Innovation Programme (FAMILY, grant agreement No 101057529; HappyMums, grant agreement No 101057390) and the European Research Council (TEMPO; grant agreement No 101039672). This research was conducted while CAMC was a Hevolution/AFAR New Investigator Awardee in Aging Biology and Geroscience Research. EW received funding from the National Institute of Mental Health of the National Institutes of Health (award number R01MH113930) and from CLOSER (ES/K000357/1) and from UK Research and Innovation (UKRI) under the UK government’s Horizon Europe / ERC Frontier Research Guarantee [BrainHealth, grant number EP/Y015037/1].

Author information

Authors and Affiliations

Authors

Contributions

KS, HT and CAMC were responsible for conceptualization of this study. KS analyzed the data from the Generation R cohort and meta-analyzed the data. KLH and CMP analyzed the data from the MoBa cohort. FS and EW analyzed the data from the ALSPAC cohort. KS, HT and CAMC interpreted the data. KS wrote the original draft of the manuscript under the supervision of HT and CAMC, and comments were provided by JFF, EW, CMP, MB, and JB. All authors read and contributed to the preparation of the final manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Charlotte A. M. Cecil.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salontaji, K., Haftorn, K.L., Sanders, F. et al. Gestational epigenetic age and ADHD symptoms in childhood: a prospective, multi-cohort study. Mol Psychiatry (2024). https://doi.org/10.1038/s41380-024-02544-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41380-024-02544-2

Search

Quick links